BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/10/2014 3:50:00 PM | Browse: 1105 | Download: 1468
 |
Received |
|
2014-02-26 14:13 |
 |
Peer-Review Started |
|
2014-02-27 21:29 |
 |
To Make the First Decision |
|
2014-03-13 18:47 |
 |
Return for Revision |
|
2014-03-23 17:50 |
 |
Revised |
|
2014-05-22 10:04 |
 |
Second Decision |
|
2014-07-22 16:50 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2014-07-22 17:10 |
 |
Articles in Press |
|
2014-07-22 18:27 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2014-08-17 14:03 |
 |
Typeset the Manuscript |
|
2014-11-18 11:41 |
 |
Publish the Manuscript Online |
|
2014-12-10 15:52 |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Retrospective Study |
Article Title |
Appropriate treatment strategies improve survival of hepatocellular carcinoma patients with portal vein tumor thrombus
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Jia-Zhou Ye, Yong-Quan Zhang, Hai-Hong Ye, Tao Bai, Liang Ma, Bang-De Xiang and Le-Qun Li |
Funding Agency and Grant Number |
|
Corresponding Author |
Le-Qun Li, MD, PhD, Professor, Department of Hepatobiliary and Pancreas Surgery, Affiliated Tumor Hospital of Guangxi Medical University, No. 71 Hedi Road, Nanning 530021, Guangxi Zhuang Autonomous Region, China. lequnlicn@126.com |
Key Words |
Hepatocellular carcinoma; Portal vein tumor thrombosis; Conservative treatment; Transarterial chemoembolization; Surgical resection; Postoperative transarterial chemoembolization |
Core Tip |
Hepatocellular carcinoma (HCC) with portal vein tumor thrombosis (PVTT) is generally considered to be related to or an absolute contraindication for hepatic resection or adjuvant chemotherapeutic methods such as transarterial chemoembolization (TACE). Only conservative and palliative treatments are available. However, many experts have indicated that surgery or TACE prolongs survival and lowers recurrence compared to palliative treatments. Thus, treatments of HCC with PVTT remain controversial. Our study explored appropriate treatment strategies and identified prognostic factors by comparing the survival periods and rates for HCC-PVTT patients with 4 kinds of treatments. |
Publish Date |
2014-12-10 15:52 |
Citation |
Ye JZ, Zhang YQ, Ye HH, Bai T, Ma L, Xiang BD, Li LQ. Appropriate treatment strategies improve survival of hepatocellular carcinoma patients with portal vein tumor thrombus. World J Gastroenterol 2014; 20(45): 17141-17147 |
URL |
http://www.wjgnet.com/1007-9327/full/v20/i45/17141.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v20.i45.17141 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345